Prognia
Drug Database
🇪🇺EU · EMALapsedATC: J07BB01

Daronrix(whole virion, inactivated, containing antigen*: A/Vietnam/1194/2004 (H5N1)* produced in eggs)

Influenza, Human;Immunization;Disease Outbreaks

Marketing Authorisation Holder: GlaxoSmithKline Biologicals S.A.

EMA Authorisation: 21/03/2007

INN: pandemic influenza vaccine (whole virion, inactivated, adjuvanted)

Indication

Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with official guidance.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Daronrix — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.